Congress and White House Press Ahead on AI in Health Care & Life Sciences

Start
Last year, both Congress and the Biden-Harris administration noticeably increased their attention on Artificial Intelligence (AI). Key congressional committees explored AI implications for health care & life sciences, and the U.S. Department of Health and Human Services (HHS) and its agencies advanced their own initiatives and as part of the federal government’s efforts to implement……
By: Akin Gump Strauss Hauer & Feld LLP
Previous Story

DoD Issues Proposed CMMC Rule Requiring Cybersecurity Assessments of Contractors

Next Story

Automated Decision Making: An EU Decision and its Implications for US Law